in the development and progression of lung cancers. It has been reported that somatic
mutations in the tyrosine kinase domain of the EGFR or ERBB2 genes occur in a subset of
patients with lung cancer. We searched for mutations of the EGFR, ERBB2, and KRAS
genes in surgically resected non-small cell lung cancers (NSCLCs) to determine the
prevalence of these mutations in Korean lung cancer patients. In addition, we examined the …